Quantity size:
0.2ml
Concentration:
1mg/ml 细胞核因子p105/k基因结合核因子抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation,细胞核因子p105/k基因结合核因子抗体 and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009].
细胞核因子p105/k基因结合核因子抗体Also known as:
NFkB p105; NFkB p105; DKFZp686C01211; DNA binding factor KBF1; DNA binding factor KBF1 EBP1; DNA binding factor KBF1 EBP1; DNA-binding factor KBF1; EBP 1; EBP-1; EBP1; KBF1; MGC54151; NF kappa B; NF kappabeta; NF kB1; NFKB 1; NFKB p105; NFKB p50; NFKB1; NFKB1_HUMAN; Nuclear factor kappa B DNA binding subunit; Nuclear factor NF kappa B p105 subunit; Nuclear factor of kappa light polypeptide gene enhancer in B cells 1; Nuclear factor of细胞核因子p105/k基因结合核因子抗体 kappa light polypeptide gene enhancer in B-cells 1; p84/NF-kappa-B1 p98.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human NFkB p105.
●
细胞核因子p105/k基因结合核因子抗体Predicted Molecular Weight: 48/105kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl124Gu01转化生长因子β1(TGFβ1)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Rb51转化生长因子β1(TGFβ1)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Ca01转化生长因子β1(TGFβ1)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Bo01转化生长因子β1(TGFβ1)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Po01转化生长因子β1(TGFβ1)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Cp01转化生长因子β1(TGFβ1)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Eq01转化生长因子β1(TGFβ1)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Ga01转化生长因子β1(TGFβ1)多克隆抗体Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl765Hu01精氨酸加压素诱导蛋白1(AVPI1)多克隆抗体Polyclonal Antibody to Arginine Vasopressin Induced Protein 1 (AVPI1)
kl765Mu01精氨酸加压素诱导蛋白1(AVPI1)多克隆抗体Polyclonal Antibody to Arginine Vasopressin Induced Protein 1 (AVPI1)
kl765Ra01精氨酸加压素诱导蛋白1(AVPI1)多克隆抗体Polyclonal Antibody to Arginine Vasopressin Induced Protein 1 (AVPI1)
kl312Hu01血管紧张素Ⅲ(AngⅢ)多克隆抗体Polyclonal Antibody to Angiotensin III (AngIII)
kl005Hu01血管紧张素Ⅱ(ANGⅡ)多克隆抗体Polyclonal Antibody to Angiotensin II (AngII)
kl851Ge01多巴胺(DA)多克隆抗体Polyclonal Antibody to Dokline (DA)
kl455Ge01雌三醇(E3)多克隆抗体Polyclonal Antibody to Estriol (E3)
kl461Ge01雌二醇(E2)多克隆抗体Polyclonal Antibody to Estradiol (E2)
kl912Ge01乙酰胆碱(ACH)多克隆抗体Polyclonal Antibody to Acetylcholine (ACH)
kl927Ge01组胺(HA)多克隆抗体Polyclonal Antibody to Histamine (HA)
kl051Ge01视黄醇(Ret)多克隆抗体Polyclonal Antibody to Retinol (Ret)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话